Yield10 Bioscience, Inc. (YTENQ)
0.0000
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
Yield10 Bioscience Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 86.67% |
| March 31, 2024 | 78.00% |
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | -188.3% |
| December 31, 2022 | -93.10% |
| September 30, 2022 | -51.35% |
| June 30, 2022 | -61.16% |
| March 31, 2022 | -3.36% |
| December 31, 2021 | 2.63% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | 0.00% |
| March 31, 2019 | 0.00% |
| December 31, 2018 | 0.00% |
| September 30, 2018 | 0.00% |
| June 30, 2018 | 0.00% |
| Date | Value |
|---|---|
| March 31, 2018 | 0.00% |
| December 31, 2017 | 0.00% |
| September 30, 2017 | 0.00% |
| June 30, 2017 | 0.00% |
| March 31, 2017 | 0.00% |
| December 31, 2016 | 0.00% |
| September 30, 2016 | 0.00% |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | 91.74% |
| June 30, 2015 | 82.53% |
| March 31, 2015 | 79.84% |
| December 31, 2014 | 78.15% |
| September 30, 2014 | -39.72% |
| June 30, 2014 | 21.71% |
| March 31, 2014 | 17.12% |
| December 31, 2013 | -12.92% |
| September 30, 2013 | 24.91% |
| June 30, 2013 | 16.06% |
| March 31, 2013 | 56.15% |
| December 31, 2012 | 55.76% |
| September 30, 2012 | 53.12% |
| June 30, 2012 | -489.7% |
| March 31, 2012 | 85.61% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Agenus, Inc. | 98.50% |
| Amgen, Inc. | 72.08% |
| Anika Therapeutics, Inc. | 65.15% |
| BioCryst Pharmaceuticals, Inc. | 98.01% |
| Imunon, Inc. | -- |